Mankind Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2025 ,inter alia, to consider and approve Pursuant to Regulation 29 and 50 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Wednesday, May 21, 2025, inter-alia to consider and approve the standalone and consolidated audited financial results of the Company for the quarter and financial year ended on March 31, 2025. Further, in continuation of our earlier letter dated March 26, 2025 under subject 'Closure of Trading Window under SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company''s ''Code of Conduct for Prevention of Insider Trading'', the trading window for trading in the securities of the Company shall remain closed till May 23, 2025